Endocrinology Flashcards
Peptide vs. Steroidal Agents
Peptide- cell surface receptor, signal transduction pathway via receptor autophosphorylation/tyrosine kinase cascade, PLC, IP3, DAG, adenylate cyclase, cAMP, PKA, etc
Injected, short half-life, frequent dosages, not orally active
Steroidal- intracellular receptor (cytoplasmic or nuclear), ligand-receptor direct binding to DNA
Very lipophillic
Tissue specific effects of insulin
Muscle and adipocyte- stimulation of glucose uptake
Liver and muscle- inhib glycogenolysis, stim glycogen synthesis
Liver- inhib gluconeogenesis
Adipocyte and liver- inhib lipolysis, stim fatty acid synthesis and esterification
Adipose- stim LPL
Liver and adrenals- stim cholesterol synthesis
Hypothalamus- suppresses appetite
All cells- stim amino acid uptake, stim protein synthesis, inhib protein degradation, stim DNA synthesis and cell proliferation, inhib apoptosis
Insulin preparations
Short acting synthetic (given with zinc for stability, clear solutions, neutral pH):
lispro- reverses amino acids B28 and B29, decreased hexamer stability
aspart- replacement of B28 proline with aspartic acid, decreased hexamer stability
glulisine- replacement of B29 lysine with glutamic acid, replacement of B3 asparagine with lysine, decreased hexamer stability
Short-acting (given with zinc for stability):
Regular (crystalline)
Intermediate-acting:
NPH (isophane)- protamine (protein that binds insulin) combined with insulin in phosphate buffer, prefered over lente, given as 70% NPH and 30% regular insulin
Lente- precipitate of insulin with increased zinc in acetate buffer. Can’t premix this, so NPH is more preferred
Long-acting:
Ultralente- increased zinc concentrations in acetate buffer. Very variable, has been replaced by glargine and detemir.
Glargine- pH of 4.0, 2 arginine residues added to C terminus of B chain and replace asparagine A21 with glycine to stabilize hexamer formation
Detemir- deleted B30 threonine and attached myristic acid to B29 lysine to stabilize hexamer formation and increases albumin binding
Sulfonylureas
MOA- stimulated insulin release via closing ATP sensitive K channels, may also potentiate insulin exocytosis by direct effect on binding proteins in secretory granules
Orally Active
Side effect- hypoglycemia
1st gen- tolbutamide, chlorpropamide (alcohol induced flush, hyponatremia), tolazamide (longer half life so harder to manage blood sugar in elderly)
2nd gen (100x more potent than 1st gen, short half-life)- glyburide, glipizide, glimepiride
Meglitinides
Repaglinide and nateglinide
Similar MOA to sulfonylureas in closing K channels
No direct effect on insulin exocytosis
No sulfur in structure (differs from sulfonylureas), so they don’t have problems with allergic responses to sulfur
Metformin
Does not cause hypoglycemia bc does not increase insulin, but it does increase the peripheral actions of insulin through AMPK
Decreases hepatic glucose output
Contraindicated with renal impairment, hepatic disease, and history of lactic acidosis (this last one is not a big deal with metformin)
Pioglitazone, rosiglitazone, troglitazone
Thiazolidinediones (drug class)
Increases insulin action by increasing glucose transporters
Binds to nuclear receptors PPARgama, regulates gene transcription, especially GLUT4
Troglitazone associated with liver failure, but need to monitor liver function with all of these drugs
Side effects- fluid retention, edema, weight gain, increase risk of heart failure (rosiglitazone and pioglitazone), increase risk of MI and stroke (rosiglitazone), increase risk of bladder cancer (pioglitazone)
Acarbose and miglitol
alpha-glucosidase inhibitors
decrease carb absorption
side effects- flatulence, diarrhea, abdominal pain
Colesevelam
bile acid binding resin
By weird mechanisms, it also lowers blood glucose
Used for type II diabetes
Exenatide
glucagon-like peptide-1 analog (GLP-1)
augments glucose-dependent insulin secretion
given by injection
also liraglutide
Sitagliptin
inhibitor of dipeptidyl peptidase-4 (DPP-4), which is the enzyme that degrades incretins like GLP-1
also saxagliptin
Pramlintide
synthetic analog of amylin
modulates postprandial glucose levels
suppresses glucagon release
delays gastric emptying
CNS anorectic effects
given as preprandial subQ injection
Drug Interactions
Hypoglycemic- ethanol, salicylates, beta-antagonists
Hyperglycemic- epinephrine, beta2-agonists, glucocorticoids, tacrolimus, thiazide diuretics, ca-channel blockers, clonidine, phenytoin, glucagon, diazoxide (can treat hypoglycemic episodes by binding to K channel and keeping it open, decreasing insulin release)
B-agonists main effects are peripherally, not at the pancreas
Vasopressin (ADH)
Receptors:
V1- PLC, PI hydrolysis, Ca, PKC, acts on vascular smooth muscle
V2- adenylate cyclase, cAMP, PKA, acts on principal cells and renal collecting duct
Desmopressin is synthetic analog that hits V2 selectively
Desmopressin
selective V2 agonist on principal cells in collecting duct
Treatment for Central and Nephrogenic Diabetes Insipidus
Central- desmopressin, chlorpropamide (enhances signal transduction), carbamazepine, clofibrate
Nephrogenic- lots of water intake, thiazide diuretics, indomethacin, amiloride (for lithium induced DI)
Treatment for SIADH
Water restriction, hypertonic saline
Demeclocycline (intereferes with V2 signal transduction), loop diuretics, lithium (last resort)
Conivaptan and tolvaptan- ADH receptor antagonists
Oxytocin (Pitocin)
Stimulates uterine contraction
Stimulates milk ejection from mammary glands
Major use is to induce labor
Other agents that stimulate uterine contraction
Can use these to treat post-partum hemorrhage
PG analogs in therapeutic abortion- misoprostol (PGE1 analog), dinoprostone (PGE2 analog)
Ergonovine/methylergonovine
Tocolytic agents
These relax uterine smooth muscle to prevent or arrest preterm labor
Beta2 selective agonists- terbutaline, ritodrine: relax smooth muscle
Nifedipine- Ca channel blocker: relax smooth muscle
Indomethacin- PG biosynthesis inhibitor, can also cause pre-mature closure of ductus arteriosus (adverse effect)
Atosiban- oxytocin receptor antagonist
GH agents
Somatropin
Mecasermin- recombinant IGF1 with binding protein, given for GH resistance (like in Loron type dwarfism)
LH agent
hCG (human chorionic gonadotropin)- acts at LH receptor
FSH agents
Menotropins- LH and FSH activity (horse urine)
Urofolitropin- mainly FSH (horse urine)
Follitropin- recombinant FSH
TSH agent
Thyrotropin- diagnostic agent used for thyroid cancer to enhance radioactive iodine uptake
Don’t really use for treatment, too expensive and it would be dumb
ACTH agent
Cosyntropin- diagnostic use
GHRH Agents
All diagnostic agents
Sermorelin- some therapeutic use, hard to mimic the pulsatile release
TRH and CRH
GnRH agents
gonadorelin- often given in pulsatile form (IV) to stimulate LH/FSH release, short-acting
Long-acting agents (some LH/FSH stim, but later get suppression):
leuprolide- subcutaneous
histrelin- subcutaneous
nafarelin- nasal spray
goserelin- subcutaneous
triptorelin- IM
ganirelix- GnRH receptor antagonist
cetrorelix- GnRH receptor antagonis
used for adjunct to infertility treatment, treatment of precocious puberty, chemical castration, prostate and breast cancer, endometriosis, and leiyomyomasassss
D2 Receptor agonists
Used to treat pituitary adenoma, especially prolactinomas and GH adenomas
Bromocriptine, cabergoline
Used to decrease prolactin secretion, “paradoxical” used to decrease GH release
Somatostatin analogs
Used to treat pituitary adenomas
Octreotide, lanreotide
Resistant to enzyme degradation, longer half-life
More selective action, more pituitary and less GI and pancreas
GH receptor antagonist
Used to treat pituitary adenoma
Pegvisomant
Thyroid hormones
Levothryoxine- T4
Liothyronine- T3
Liotrix- T4 and T3
Use nuclear receptors
Used to treat hypothyroidism, cretinism, suppresses TSH in treatment of thyroid cancer
High doses causes cardiac arrhythmias
Drug interactions- estrogens increase binding of T4 to TBG, glucocorticoids and androgens and salicylates decrease binding of T4 to TBG, propranolol and glucocorticoids and PTU and amiodarone and radiology contrast agents inhibit T4 to T3 conversion
Propylthiouracil
Inhibits thyroid hormone synthesis via a few different mechanisms: Inhibits peroxidase oxidation of iodide and inhibits coupling reactions of DIT and MIT. Inhibits peripheral deiodination of T4 to T3 (could make a difference if there is severe thyroid excess, would be better than methimazone in this regard)
75 min half-life (shorter than methimazole)
Can cause agranulocytosis (rare), fever, rash
Methimazole
Inhibits peroxidase oxidation of iodide and inhibits coupling reactions of DIT and MIT
Half life of 4-6 hours
Less frequent dosing, easier for patients
Can cause agranulocytosis (rare and would happen early on), fever, rash and obviously, hypothyroidism
Thiocyanate, perchlorate, fluroborate
Anti-thyroid drugs (ionic inhibitors)
Interferes with iodide concentration via blocking iodide transporter. compete with Iodide.
These are toxic agents and so not frontline drugs. Can get fatal aplastic anemia with perchlorate
Iodine131
Anti-thyroid agent
Acts the same as regular iodine
Used in older patients. Treatment with this often leads to hypothyroidism but it’s easy to bring them back to euthyroidism via thyroid hormones
Used to treat metastatic thyroid carcinoma along with TSH (enhance uptake of radioactive iodine)
Contraindicated in pregnant patients and children
I123 : diagnostic use
Glucocorticoids
Like other steroids, lipophilic and well absorbed orally.
Once in cytosol binds to GR (HSP is kicked off) and diffuses to nucleus where transcription occurs.
carbohydrate, protein, lipid “central sparing, peripheral wasting”
Uses: replacement therapy, Congential adrenal hyperplasia (ex: 21 alpha hydroxylase def), inflammatory states, asthma, immunosuppressive (transplant), ulcerative colitis
Overdose will look like a Cushing’s patient. Exogenous cortisol will cause feedback inh on Pituitary will result in decreased ACTH: Adrenals will atrophy